Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.34 (
lipoprotein lipase
)
7,025
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Activatable
cholesterol esterase
and triacylglycerol lipase of rat adrenal were 58-69% recovered in the 100 000 X g supernatant fraction. Activatable triacylglycerol lipase activity was differentiated from the activity of acid lipase and
lipoprotein lipase
also found in this fraction. Cholesterol esterase was activated 39.7 +/- 13.6% (S.D.) and triacylglycerol lipase 11.9 +/- 2.9% in a reaction dependent on ATP, cyclic AMP, and protein kinase. The two activities were shown by differential inhibition by an organophosphate, and by partial separation on salting out, to be largely due to separate enzymes. The two enzymes bound tightly to substrate emulsions with quantitatively similar distribution between competing emulsions, suggesting concerted binding. Coinciding gel filtration patterns reinforced, The hypothesis of a lipase complex. Cholesterol esterase comprised a major component of higher apparent Km for substrate and molecular weight 3-10(5)-6-10(5) by gel filtration and a minor component of lower apparent Km and heterogeneous molecular weight above 1 million, which was found mostly in complex and lipid.
...
PMID:Activatable cholesterol esterase and triacylglycerol lipase activities of rat adrenal and their relationship. 6 45
Phthalazinol (EG 626), a thromboxane A2 antagonist and cyclic AMP phosphodiesterase inhibitor, has been shown to prevent the atherosclerosis induced in cholesterol fed rabbits. In an attempt to clarify the antiatherosclerotic mechanism, the effects of this compound on the lipolytic enzyme activities (
cholesterol esterase
and
lipoprotein lipase
) of rat aorta were examined in vivo. Administration of EG 626 (100-200 mg/kg, per os, daily, 1-2 weeks) affected neither the aortic lysosomal
cholesterol esterase
nor the acid phosphatase activity, whereas the
lipoprotein lipase
activity was signficantly decreased by the treatment. These results suggest that with an elevation in HDL-cholesterol, a decrease in
lipoprotein lipase
activity after ingestion of EG 626 might contribute, at least to some extent, to the prevention of arterial lipid accumulation.
...
PMID:Effects of phthalazinol (EG 626) on arterial lipolytic enzyme activities in the rat. 23 31
Lipolysis of intracellular triglycerides in the heart has been shown to be regulated by hormones. However, activation of myocardial triglyceride lipase in a cell-free system has not been directly demonstrated. In the present studies, initial attempts to demonstrate cAMP-dependent activation of triglyceride lipase using the 1,000 X g supernatant fraction (S1) of mouse heart homogenate were unsuccessful, presumably due to the masking effects of high levels of
lipoprotein lipase
activity even when assayed at pH 7.4 and in the absence of apolipoprotein C-II. Myocardial
lipoprotein lipase
in the 40,000 X g supernatant fraction was then removed by heparin-Sepharose affinity chromatography. The
lipoprotein lipase
-free fractions were shown to contain neutral triglyceride lipase and neutral
cholesterol esterase
of about equal activities. The triglyceride lipase and
cholesterol esterase
activities fell progressively during preincubation in the presence of 5 mM Mg2+. Additions of cAMP and ATP resulted in 40-70% activation of both triglyceride lipase and
cholesterol esterase
. The activation was blocked by protein kinase inhibitor and was restored by the addition of exogenous cAMP-dependent protein kinase. Since
lipoprotein lipase
has no activity toward cholesteryl oleate, activation of
cholesterol esterase
in untreated S1 was readily demonstrable. Both triglyceride lipase and
cholesterol esterase
activities were present in homogenates prepared from isolated rat heart myocytes. We conclude that the myocardium contains a hormone-sensitive lipase that is regulated in a fashion similar to that of the adipose tissue enzyme.
...
PMID:Activation of myocardial neutral triglyceride lipase and neutral cholesterol esterase by cAMP-dependent protein kinase. 298 7
We have investigated the composition of breast milk from a patient with abetalipoproteinemia. Activity level and specific activity of
lipoprotein lipase
in milk samples obtained at 0.5 and 3 mo postpartum were higher than those found in normal milk; activity of
bile salt-activated lipase
was found to be higher in the milk at 6 mo postpartum than in normal milk but average specific activity of this enzyme in milk samples was not increased. Except for higher protein content of patient's milk, there was no apparent abnormality in the protein pattern as determined by SDS-polyacrylamide gel electrophoresis. Lipid analysis indicated a shift in the molecular weight distribution of triglycerides, which favored lower molecular weight forms and reflected an increase in medium-chain and a major decrease in long-chain essential fatty acids (omega 6 and omega 3) in milk triglycerides.
...
PMID:Lipid composition and lipolytic activities in milk from a patient with homozygous familial hypobetalipoproteinemia. 356
The
cholesterol esterase
and
lipoprotein lipase
catalyzed hydrolyses of the water-soluble substrate p-nitrophenyl butyrate are competitively inhibited by butaneboronic acid and phenylboronic acid. Phenyl-n-butylborinic acid has been synthesized and characterized as an ultrapotent transition state analog inhibitor: Ki = 2.9 +/- 0.6 nM and 1.7 +/- 0.3 microM for the
cholesterol esterase
and
lipoprotein lipase
reactions, respectively. These results are interpreted in terms of transition state structure and stabilization.
...
PMID:Phenyl-n-butylborinic acid is a potent transition state analog inhibitor of lipolytic enzymes. 394 31
Differentiation of 3T3-L1 fibroblasts to adipocyte-like cells was accompanied by a 19-fold increase in neutral triglyceride lipase activity, a 12-fold increase in
diglyceride lipase
activity, a 10-fold increase in monoglyceride lipase activity, and a 280-fold increase in
cholesterol esterase
activity. In contrast, acid acylhydrolase activities did not increase during differentiation. The rate of glycerol release from unstimulated intact cells increased by more than 1 order of magnitude upon differentiation. Isoproterenol (1 microM) and 1-methyl-3-isobutylxanthine (0.1 mM) further stimulated this rate of glycerol release 3-fold. The neutral triglyceride lipase activity in cell-free preparations of differentiated cells was activated 105% by cyclic AMP-dependent protein kinase. Neutral
cholesterol esterase
,
diglyceride lipase
, and monoglyceride lipase were also activated (117%, 10%, and 37+, respectively) by cyclic AMP-dependent protein kinase. In contrast, protein kinase had no effect on any of the four lysosomal acid acylhydrolase activities. Thus, hormone-sensitive lipase, the most characteristic and functionally important enzyme of adipose tissue, has been characterized in differentiated 3T3-L1 cells. The 3T3-L1 cell should be a valuable model system in which to study regulation of hormone-sensitive lipase, particularly its long-term regulation.
...
PMID:Hormone-sensitive lipase in differentiated 3T3-L1 cells and its activation by cyclic AMP-dependent protein kinase. 626 67
Atherosclerotic lesions were formed in the aorta of rats given a high cholesterol diet containing propylthiouracil (PTU) and vitamin D2 (atherogenic diet) for 8 weeks. The effects of niceritrol (pentaerythritol tetranicotinate), which lower the plasma lipid level, on lipid metabolism in the arterial wall of the atherosclerotic rats were studied. Niceritrol significantly decreased the plasma cholesterol level of atherosclerotic rats, which was 823 mg/100 ml, or about ten times that of control rats. On treatment with niceritrol, the cholesterol level was reduced most in the very low density lipoprotein (VLDL) fraction (d less than 1.006). Heparin-releasable
lipoprotein lipase
activity in epididymal adipose tissue,
lipoprotein lipase
activity in post-heparin plasma, and VLDL-triolein hydrolyzing activity in adipose tissue stromal vessels were all higher in niceritrol-treated atherosclerotic rats. Of the enzymes in the arterial wall concerned with cholesterol ester metabolism, acid
cholesterol esterase
activity was decreased in atherosclerotic rats, while niceritrol treatment increased this activity. The ratio of acyl-CoA cholesterol acyltransferase activity (ACAT) to neutral
cholesterol esterase
activity was higher in atherosclerotic rats than in control rats, but was lower in niceritrol-treated rats than in atherosclerotic rats. From these results, it is concluded that niceritrol modifies enzyme activities in such a way as to reduce the cholesterol ester content of the arterial wall and lower plasma VLDL and LDL cholesterol levels.
...
PMID:Effect of niceritrol on lipid metabolism of aorta in atherosclerotic rats. 647 52
The effects of 17 beta-estradiol and testosterone administration on
cholesterol esterase
,
lipoprotein lipase
activities and adrenalin-induced lipolysis were examined in rat adipose tissues with the change in serum lipid level. The administration of 17 beta-estradiol (500 micrograms/kg, 2 or 4 weeks) to male rats significantly reduced the body weight, and markedly increased serum cholesterol, triacylglycerols and phospholipids. Cholesterol esterase activity was significantly enhanced in the epididymal adipose tissue from estradiol treated rats and the effect was greater with duration of the treatment. In contrast,
lipoprotein lipase
activity was markedly reduced. Testosterone reduced
cholesterol esterase
activity in the parametrial adipose tissue through the treatment with 500 micrograms/kg for 6 weeks, but it did neither influence serum lipids nor
lipoprotein lipase
activity. Basal lipolysis and adrenalin-induced lipolysis were also significantly enhanced in the epididymal adipose tissue from the male rat treated either with 7 mg/kg estradiol 12 h ahead or with 500 micrograms/kg estradiol for 2 weeks. These results indicate that estradiol exerts strong effects on metabolism of the adipose and these effects seems to be mediated through cyclic-AMP. An alteration of adrenergic functions by gonadal steroids might be intervened.
...
PMID:Enhancement in cholesterol-esterase activity and lipolysis due to 17 beta-estradiol treatment in rat adipose tissue. 650 Apr 87
Atherosclerotic lesions formed in the aorta of rats given diet containing propylthiouracil (PTU), vitamin D2 and high cholesterol diet (atherogenic) for 8 weeks. The effect of clinofibrate, which lowers the plasma lipid level, on lipid metabolism in the arterial wall of the atherosclerotic rats was studied. Clinofibrate significantly decreased the high plasma cholesterol level of atherosclerotic rats, which was 823 +/- 256 (mean +/- SD) mg/dl, or about ten times that of control rats (85 +/- 11 mg/dl). On treatment with clinofibrate, the cholesterol level was reduced most in the very low density lipoprotein (VLDL) fraction (d less than 1.006). Heparin-releasable
lipoprotein lipase
activity in epididymal adipose tissue,
lipoprotein lipase
activity in post heparin plasma, and VLDL-triolein hydrolizing activity in adipose tissue stromal vessels were higher in clinofibrate-treated rats than in atherosclerotic rats. Of the enzymes in the arterial wall concerned with cholesterol ester metabolism, acid
cholesterol esterase
activity was decreased in atherosclerotic rats, and clinofibrate treatment increased this activity. The ratio of acyl-CoA cholesterol acyltransferase activity (ACAT) to neutral
cholesterol esterase
activity was higher in atherosclerotic rats than in control rats and was lower in clinofibrate-treated rats than in atherosclerotic rats. From these results, it is concluded that clinofibrate modifies enzyme activities in such a way as to cause a reduction of cholesterol accumulation in the arterial wall and lowers the plasma VLDL and LDL cholesterol levels.
...
PMID:Effect of clinofibrate on lipid metabolism of aorta in atherosclerotic rats. 668 Sep 96
High levels of neutral triglyceride lipase activity have been demonstrated in several types of macrophages (J774 cells, human monocyte/macrophages, rabbit alveolar macrophages, and resident mouse peritoneal macrophages). The pH optima ranged from 6.5 to 7.4 depending upon the buffer and the conditions of incubation. The addition of bovine serum albumin stimulated activity at low concentrations, as expected for a fatty acid-releasing reaction, but strongly inhibited at higher concentrations; maximal activity was observed in the presence of 0.625 mg/ml of bovine serum albumin. The enzyme was remarkably thermostable, showing no apparent loss of activity at 50 degrees C for as long as 6 hours. The lipase was inhibited 80% by 0.1 M NaCl. Assayed under optimal conditions, the specific activity of the neutral triglyceride lipase from J774 cells was more than 100-fold greater than the activity of
lipoprotein lipase
or neutral
cholesterol esterase
from those cells; this activity was 10-fold greater than the levels of hormone-sensitive lipase from 3T3-L1 adipocytes. This neutral triglyceride lipase may play an important role in the degradation and mobilization of cytosolic triglyceride in macrophage-derived foam cells.
...
PMID:Neutral triglyceride lipase in macrophages. 669 44
1
2
3
Next >>